Intellia Therapeutics (NTLA) FCF Margin Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,630.00 |
| Dec 31, 2025 | 29,255.00 |
| Sep 30, 2025 | -41,978.00 |
| Jun 30, 2025 | -105,436.00 |
| Mar 31, 2025 | -10,840.00 |
| Dec 31, 2024 | -34,337.00 |
| Sep 30, 2024 | -70,556.00 |
| Jun 30, 2024 | -55,669.00 |
| Mar 31, 2024 | -21,577.00 |
| Dec 31, 2023 | 491,420.00 |
| Sep 30, 2023 | -57,720.00 |
| Jun 30, 2023 | -40,869.00 |
| Mar 31, 2023 | -63,498.00 |
| Dec 31, 2022 | -22,909.00 |
| Sep 30, 2022 | -45,904.00 |
| Jun 30, 2022 | -26,811.00 |
| Mar 31, 2022 | -55,281.00 |
| Dec 31, 2021 | -18,553.00 |
| Sep 30, 2021 | -2.30 Mn |
| Jun 30, 2021 | -245,342.00 |
| Mar 31, 2021 | -24,482.00 |
| Dec 31, 2020 | -12,702.00 |
| Sep 30, 2020 | -146.00 |
| Jun 30, 2020 | 24,041.00 |
| Mar 31, 2020 | -112,264.00 |